Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
07/1999
07/20/1999US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis
07/13/1999US5922876 Preparation of oxymorphone from morphine
07/08/1999WO1999033797A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)
07/08/1999WO1999033781A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
07/07/1999EP0927555A1 Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia
07/06/1999US5919809 3-substituted-2-oxindole derivatives
07/06/1999US5919795 Atherosclerosis therapy
07/06/1999CA2009578C Excitatory amino acid receptor antagonists
07/06/1999CA1340626C Sulfonated 2-(2'-hydroxyaryl)-2h-benzotriazoles and their use to improve stain resistance and dye lightfastness
07/01/1999WO1999032081A1 Transmucosal formulations of levosimendan
06/1999
06/30/1999CN1221407A Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
06/30/1999CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof
06/29/1999US5917048 Substituted aryl or heteroarylamides having retinoid-like biological activity
06/29/1999US5916920 Controlling neurotransmitter recpetors; nervous system disorders, psychological disorders
06/29/1999US5916897 Process for the preparation of 9-amino camptothecin
06/24/1999WO1999031099A1 Integrin receptor antagonists
06/24/1999WO1999031093A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
06/24/1999WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor
06/24/1999CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor
06/24/1999CA2314967A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
06/23/1999EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor
06/23/1999EP0639186B1 Taxol derivatives
06/23/1999EP0638068B1 Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines
06/23/1999CN1043761C Fluorinated hydroxyalkylquinoline acid and medicinal salt and its drug composition
06/22/1999US5914400 Method and compositions for the synthesis of BCH-189 and related compounds
06/22/1999US5914332 Retroviral protease inhibiting compounds
06/22/1999US5914263 Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
06/16/1999EP0757684B1 Process for the diastereoselective synthesis of nucleoside analogues
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219537A Process for preparing benzofuranone derivatives
06/16/1999CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds
06/09/1999EP0920438A2 N6 heterocyclic substituted adenosine derivatives
06/09/1999EP0920422A1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
06/09/1999EP0799223B1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/08/1999CA2089972C Sulfonamidocarboxamides
06/02/1999EP0581939B1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
06/02/1999CN1218472A Pharmaceutically useful compounds
06/02/1999CN1218471A Carboline derivatives
06/02/1999CN1043528C Method for preparation of taxol using an oxazinone
06/01/1999US5908941 Reactin a chemical intermediate with an acid in presence of an aprotic solvent
05/1999
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/20/1999WO1999024433A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
05/19/1999EP0916666A1 3-alkyloxy-,aryloxy-, or arylalkyloxy-benzo[b]thiophene-2-carboxamides as inhibitors of cell adhesion
05/19/1999EP0915880A1 Azolo triazines and pyrimidines
05/19/1999EP0915879A1 Novel compounds
05/19/1999EP0915875A2 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
05/14/1999WO1999022722A2 Use of macrolides for the treatment of cancer and macular degeneration
05/14/1999CA2307850A1 Use of macrolides for the treatment of cancer and macular degeneration
05/11/1999US5902814 Treating psychotic disorder, intellectual disorders and anxiety, such as attention deficit hyperactivity disorder and schizophrenia
05/06/1999EP0912572A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912570A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912567A1 Carboline derivatives
05/06/1999EP0582581B1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES
05/05/1999CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors
05/04/1999US5900424 Omeprazole magnesium salt form
04/1999
04/28/1999EP0911322A2 1-Benzyl-3-(S)-[2-(S)-(tert-butoxy-carbonylamino) propionylamino] -pyrrolidine and its use as an intermediate
04/28/1999EP0910563A1 Integrin receptor antagonists
04/28/1999EP0910372A1 Pharmaceutical compositions containing mesembrine and related compounds
04/28/1999CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists
04/22/1999WO1999019308A1 Process and intermediates for the preparation of a triazoline herbicide
04/22/1999WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders
04/21/1999CN1214685A Inhibitors of farnesyl protein transferase
04/21/1999CN1043042C Resolution method of alpha-(2,2-dimethylpropionyloxy) ethyl 7-[2-(2-amino-thiazol-4-yl)-2-(2)-hydroxyl-imino-acetamido]-3-(methoxy methyl)-3-cephem-4-carboxylate
04/15/1999WO1999018075A1 Novel dihydronaphthalene compounds and process for producing the same
04/15/1999WO1999005103A3 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent
04/15/1999CA2298527A1 Novel dihydronaphthalene compounds and process for producing the same
04/08/1999WO1999016438A1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
04/01/1999WO1999015525A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999CA2304397A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
03/1999
03/31/1999EP0905136A1 Tetrahydro gamma-carbolines
03/30/1999US5889032 Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/30/1999US5889026 N-methyl-d-asparatate-receptor subtype selective blocker
03/30/1999US5889025 Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/30/1999US5889021 Active Compounds
03/25/1999WO1999014199A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
03/24/1999EP0902683A1 AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES
03/24/1999CN1211983A Azabicyclic esters of carbamic acids useful in therapy
03/23/1999US5886036 Treating hiv infections
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1998057937A3 Inhibitors of factor xa with a neutral p1 specificity group
03/18/1999DE19740110A1 New hydroxy substituted benzomorphan derivatives
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999CN1210856A Process for preparation of heteroarylcarboxamides
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883112 Synergistic compositions comprising pesticidal 5-amino-4-ethylsulfinyl-1-arylpyrazoles and piperonyl butoxide
03/16/1999US5883102 Pharmaceutically active compounds
03/10/1999CN1042421C Preparation of acridine derivatives
03/03/1999EP0899262A2 Process for the preparation of heteroarylcarboxylic amides and esters
03/03/1999EP0674641B1 Pyrrolopyrimidines as crf antagonists
03/03/1999CN1209802A Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
03/03/1999CN1042331C 4,6-dichloro-3-substituted-2-carboxy indole derivative
02/1999
02/25/1999WO1999009021A1 Process for selective derivatization of taxanes
02/25/1999WO1999009015A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
02/25/1999WO1999009013A1 Fluoropyrazole-biphenylamide fungicides
02/25/1999WO1999008500A2 New crystalline form of omeprazole
02/25/1999WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 105